期刊文献+

PF方案联合放射治疗晚期食管癌的疗效观察 被引量:2

Therapeutic results of PF regimen chemotherapy combined with radiation therapy in the treatment of advanced esophageal carcinonma
下载PDF
导出
摘要 目的探讨PF方案联合放射治疗晚期食管癌的疗效及毒副反应。方法回顾分析68例食管癌的随访资料,根据治疗方法不同分为PF方案联合放射治疗组和单纯放疗组,应用χ2检验分析肿瘤的缓解率、患者的生存率及毒副反应。结果PF方案联合放疗组在肿瘤的消失、缩小方面优于单纯放疗组,两者差异有显著意义(P<0.05)。化疗联合放疗组1、2、3、5年的生存率明显高于单纯放疗组,两者有显著性差异(P<0.05);但化疗联合放疗组较单纯放疗组消化道I-II度毒副反应发生率明显增加,差异有显著性意义(P<0.05)。结论PF方案联合放射治疗晚期食管癌是目前较为理想的治疗方案。 Objective To explore the curative effect and side-effects of PF regimen combined with radiation therapy in the treatment of advanced esophageal cancer.Methods Data of sixty eight esophageal cancer patients were analyzed retrospectively. The patients were divided into two groups based on different treatment methods. Group A received PF regimen chemotherapy combined with radiation therapy, while group B received radiation therapy only. χ~2 test was used to analyze the tumor remission rate, survival rate and side-effects.Results PF regimen chemotherapy combined with radiation therapy was more effective than radiation therapy. One, two, three and five-year survival rates of group A were significant higher than those of group B respectively. However,ⅠtoⅡgrade gastrointestinal tract toxicity of group A was more than group B.Conclusion PF regimen chemotherapy combined with radiation therapy is currently an effective method in the treatment of advanced esophageal cancer.
出处 《现代肿瘤医学》 CAS 2005年第4期500-501,共2页 Journal of Modern Oncology
关键词 放射治疗 PF方案 晚期食管癌 radiation therapy PF regimen advanced esophageal cancer
  • 相关文献

参考文献7

二级参考文献24

  • 1[3]KoKTC.Chemotherapy in oesphageal cancer[J].Cancer Treat Rev,1997,23:65~85.
  • 2[1]Coia LR, Minsky BD, John MJ, et al. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992 ~ 1994 patterns of care study[J]. Cancer, 1999, 85(12): 2499 ~ 2505.
  • 3[2]Tanisadak K, Teshima T, Inoue T, et al. National average for the process of radiation therapy in Japan by patterns of care study [ J]. Jpn J Clin Oncol, 1999, 29 (4):209~ 213.
  • 4[4]Gaspar LE, Nag S, Herskovic A, et al. American Brachytherapy Sooiety (ABS) consensus guidelines for brachytherapy of esophageal cance[J]. Int J Radiat Oncol Biol Phys, 1997,38(1): 127~ 132.
  • 5[5]Taal BG, Aleman BM, Koning CC, et al. High dose rate brachytherapy before external beam irradiation in inoperaple esophageal cancer [J]. Br J Cancer, 1996,74(9): 1452 ~ 1457.
  • 6[6]Akagi Y, Hirokawa Y, Kagemoto M, et al. Optimum fractionation for high- dose-rate endoesophageal brachytherapy following external beam irradiation of early stage esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 1999,43(3): 525~530.
  • 7[7]OkawaT, dokiyaT, NishioM, etal. Multi- institutiooal randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. JASTRO study group [ J]. Int J Radiat Onool Biol Phys, 1999, 45(3): 623~628.
  • 8[8]Yorozu A, Dokiya T, Oki Y, et al. Curative radiotherapy with highdose-rate brachytherapy boost for localized esophageal cancer: doseeffect relationship of brachytherapy with the balloon type applicator system [J]. Radiother Onool , 1999, 51(2):133~ 139.
  • 9[9]Ogawa K, Toita T, Kakinohana Y, et al. Intraluminal brachytherapy using a balloon applicator for superficial esophageal carcinoma: importance of applicator confirmation by computed tomography [ J ]. Radiat Med, 1999,17(5) :399 ~ 402.
  • 10[10]Yorozu A, DokiyaT, Oki Y, etal. High-dose- ratebrachytherapy boost following concurrent chemoradiotherapy for esophageal cancer [J]. Int J Radiat Oncol Biol Phys, 1999, 45(2): 271 ~ 275.

共引文献29

同被引文献17

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部